InsidersTradesSigma
Browse the full record of transactions filed by Peterson Tycho, 首席财务官. Director active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 1 reports have been recorded. Activity tracked since 1 June 2022. The latest transaction was filed on 1 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Tycho Peterson is the Chief Financial Officer at Adaptive Biotechnologies Corp. He oversees the financial management of the company, including financial planning, analysis, and risk management. His role is essential in ensuring the financial health of the organization and supporting its growth objectives. With extensive expertise in finance, he contributes to strategic decision-making that fosters innovation in the biotechnology sector.